Management of Lactate Levels in ESRD
Bicarbonate-buffered solutions should be used instead of lactate-buffered solutions for dialysis in ESRD patients with elevated lactate levels or risk factors for lactic acidosis. 1
Pathophysiology of Lactate in ESRD
Patients with end-stage renal disease (ESRD) have impaired ability to excrete acid produced by normal metabolic processes, which can contribute to acid-base disturbances. Additionally, ESRD patients may have:
- Baseline abnormal lactate levels (prevalence of 17.7% in outpatient ESRD population) 2
- Reduced ability to metabolize exogenous lactate from dialysis solutions
- Risk of developing lactic acidosis, particularly when using lactate-buffered solutions in certain clinical scenarios
Assessment of Lactate Levels
- Monitor serum lactate levels regularly in ESRD patients
- Pay particular attention to lactate levels in patients with:
- Liver dysfunction
- Cardiovascular instability
- Sepsis or other hypoperfusion states
- Medications that may increase lactate (e.g., metformin)
Management Algorithm for Lactate in ESRD
1. Choice of Buffer in Dialysis Solutions
- First-line choice: Bicarbonate-buffered solutions for all ESRD patients 1
- Avoid lactate-buffered solutions in patients with:
- Elevated baseline lactate levels
- Liver dysfunction
- Hemodynamic instability
- Lactic acidosis
- Sepsis or shock states
2. Monitoring During Dialysis
- Monitor acid-base status during dialysis, particularly when using lactate-buffered solutions
- Watch for signs of worsening acidosis:
- Decreasing serum bicarbonate
- Increasing anion gap
- Hemodynamic instability
3. Management of Elevated Lactate
For mild elevation:
- Switch from lactate-buffered to bicarbonate-buffered dialysis solutions
- Optimize hemodynamics to improve tissue perfusion
- Consider increasing dialysis dose to enhance lactate clearance
For severe elevation or lactic acidosis:
- Immediate hemodialysis with bicarbonate buffer
- Correct underlying causes (hypoperfusion, medication effects)
- Consider bicarbonate supplementation if severe acidosis is present
4. Special Considerations
- Metformin users: Discontinue metformin in ESRD patients (contraindicated with eGFR <30 mL/min/1.73m²) 3
- Hemodynamically unstable patients: Avoid lactate-buffered solutions as they can worsen hypotension 4
- Patients with liver dysfunction: Use bicarbonate-buffered solutions exclusively as these patients have impaired lactate metabolism 5
Evidence Quality and Considerations
The recommendation to use bicarbonate-buffered solutions is supported by moderate-quality evidence. A study by Davenport et al. demonstrated that patients with hepatorenal failure developed worsening acidosis when given lactate-buffered solutions, with a correlation between maximum blood lactate and increase in arterial hydrogen ion concentration (r = 0.76, P < 0.001) 5.
Hemodialysis itself can significantly reduce elevated lactate levels, with one study showing an overall decrease of 27% after dialysis, and even greater reductions (62%) in patients with higher baseline lactate levels (2.5-3.9 mmol/L) 2.
Common Pitfalls to Avoid
- Using lactate-buffered solutions in all patients: This can worsen acidosis in vulnerable patients
- Ignoring baseline lactate levels: Pre-dialysis assessment of lactate is important for proper buffer selection
- Overlooking medication effects: Certain medications like metformin can contribute to lactic acidosis and should be discontinued in ESRD patients
- Failing to monitor acid-base status during dialysis: Regular monitoring is essential, especially in high-risk patients
By following this approach, clinicians can effectively manage lactate levels in ESRD patients and minimize the risk of complications related to acid-base disturbances.